Loading…
← CockpitCompetitor Analysis › 603192.SS Shanghai Huide Science & Technology Co., Ltd. Class AOpen in the cockpit ↗

Shanghai Huide Science & Technology Co., Ltd. Class A603192.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum neutral 47
Mkt cap
$476M
US dollars, full cap
$/day
$7.10M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-3.8 pp
WACC 7.5%
Hurdle
+5 pp
Req g minus delivered
Close · CNYCN¥19.23
1D+0.9%
1W-0.7%
1M-9.1%
3M-12.1%
6M-15.4%
YTD-26.7%
1Y-39.5%
ATR %5.2%
52w lowhigh49.9% off high

What Shanghai Huide Science & Technology does

Employees: 951

Shanghai Huide Science & Technology at a glance

Size Shanghai Huide Science & Technology (603192.SS) is a China Materials company (Chemicals: Specialty) with a market value of $476M, the 3971st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥19.23 on 6 Nov 2026.

Performance Over six months the shares fell 15.4%, against -16.0% for the median peer and -16.4% for the China market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 1.7% over the last twelve months (peer median +14.7%); the operating margin is 3.0% (peer median 4.6%).

Valuation It trades at 1.0× enterprise value to sales against a peer median of 1.5× (6th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.8 points below its cost of capital (7.5% WACC).

Relative performance

809010011 May 202611 Aug 20266 Nov 2026Peer median 87603192.SS 84
Six months, rebased to 100: Shanghai Huide Science & Technology against the median of its 20 peers (local-currency closes).

Shanghai Huide Science & Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥2.58BCN¥2.47BCN¥2.67BCN¥2.70BCN¥3.01B
Revenue growth—-7%-1%-10%—
Gross profitCN¥324MCN¥342MCN¥352MCN¥261MCN¥266M
EBITDACN¥153MCN¥165MCN¥215MCN¥139MCN¥120M
Net incomeCN¥71.9MCN¥81.3MCN¥125MCN¥63.9MCN¥61.9M
Free cash flowCN¥170MCN¥204M-CN¥21.6MCN¥193M-CN¥40.6M
Capital expenditureCN¥38.9MCN¥125MCN¥49.5MCN¥46.3MCN¥97.9M
Total debtCN¥495MCN¥480MCN¥508MCN¥722MCN¥690M

Quarterly statements and history in the cockpit →

Shanghai Huide Science & Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-30%-20%-10%0%GUJALKALI688203002109600800036830LXCHEM60539960312000205407463009276037257942SOTL3001321714BAKLCFSVHI603192.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shanghai Huide Science & Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%1×2×3×4×GUJALKALI688203002109600800036830LXCHEM60539960312000205407463009276037257942SOTL3001321714BAKLCFSVHI002453603192.SSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanghai Huide Science & Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%GUJALKALI688203002109603120002054074630092779423001321714LCFSVHI603192.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shanghai Huide Science & Technology is the large dot.

Shanghai Huide Science & Technology competitors and peer comparison

How Shanghai Huide Science & Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanghai Huide Science & Technology against its 20 peers (data as of 6 Nov 2026)
Measure603192.SSPeer medianRank in peer set
1-month return-9.1%-13.9%7th highest of 21
6-month return-15.4%-16.0%11th highest of 21
Distance from 52-week high-49.9%-39.0%5th lowest of 21
Revenue growth (TTM)+1.7%+14.7%5th lowest of 21
Operating margin3.0%4.6%10th lowest of 21
EV / Sales1.0×1.5×6th cheapest of 21
Growth the price implies (Req g, 7 yrs)15.5%9.8%8th least demanding of 15
Growth delivered (Del g)+10.5%+12.7%7th lowest of 15
Hurdle (Req g minus delivered)+5.0 pp-10.5 pp5th most demanding of 15
ROIC minus cost of capital-3.8 pp-1.8 pp9th lowest of 21
EV / EBITDA16.4×8.9×3rd most expensive of 10
Net debt / EBITDA-4.2×1.4×least indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Shanghai Huide Science & Technology 603192.SSChina$476M-15%+2%3%1.0×15.5%+10.5%
Gujarat Alkalies & Chemicals GUJALKALI.NSIndia$476M-23%+7%2%1.0×39.8%+12.5%
Zhejiang Hisun Biomaterials 688203.SSChina$473M+16%+47%4%2.5×16.5%+26.6%
Shaanxi Xinghua Chemistry 002109.SZChina$473M-39%+20%-1%1.6×2.0%+13.0%
Tian Jin Bohai Chemical 600800.SSChina$479M-37%-24%-20%1.7×n/an/a
Soulbrain 036830.KSSouth Korea$480M-55%+16%-3%1.5×n/an/a
Laxmi Organic Industries LXCHEM.NSIndia$480M0%+5%6%1.4×n/an/a
Jiangxi Chenguang New Materials 605399.SSChina$482M-30%+15%-9%2.8×n/an/a
Kente Catalysts 603120.SSChina$465M+6%+9%12%3.9×18.3%-8.9%
Dymatic Chemicals 002054.SZChina$465M-25%+21%8%1.7×-0.8%+12.9%
Lee & Man Chemical 0746.HKHong Kong$465M-9%+3%18%1.1×-8.5%+3.9%
Nantong Jiangtian Chemical 300927.SZChina$463M-29%+51%5%1.7×18.0%+29.0%
Guangdong Tianan New Material 603725.SSChina$489M+9%-12%2%1.5×21.7%+29.0%
JSP 7942.TJapan$462M+29%+14%8%0.5×-4.0%+7.2%
Savita Oil Technologies SOTL.NSIndia$491M+61%+26%10%1.0×17.5%+16.8%
FuJian Nox Bellcow 300132.SZChina$459M-37%+18%7%1.0×3.1%-10.5%
Ho Tung Chemical 1714.TWTaiwan$459M+67%+36%10%0.5×-17.3%-1.5%
Braskem S.A. Sponsored ADR Pfd BAKUnited States$457M-70%-1%1%0.9×n/an/a
Tidewater Renewables LCFS.TOCanada$495M+97%+24%20%2.4×-3.0%+126.4%
Valhi VHIUnited States$456M+11%+3%1%0.6×32.2%+2.3%
Great Chinasoft Technology 002453.SZChina$497M-27%-5%-54%8.2×n/an/a

Questions

Which companies are Shanghai Huide Science & Technology's closest peers?
The cockpit's peer set: Gujarat Alkalies & Chemicals (GUJALKALI.NS), Zhejiang Hisun Biomaterials (688203.SS), Shaanxi Xinghua Chemistry (002109.SZ), Tian Jin Bohai Chemical (600800.SS), Soulbrain (036830.KS), Laxmi Organic Industries (LXCHEM.NS), Jiangxi Chenguang New Materials (605399.SS), Kente Catalysts (603120.SS).
Is Shanghai Huide Science & Technology expensive compared with its peers?
On ev / sales it trades at 1.0× against a peer median of 1.5×, 6th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Shanghai Huide Science & Technology stock performed?
Over six months to 6 Nov 2026 the shares returned -15.4% against -16.0% for the median peer; over one year -39.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.